Health
NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms – News-Medical.net
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, the ACTIV-6 trial aims to provide evidence-based…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News24 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
Business23 hours agoASX ETFs to target amidst an ageing population
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute